Amazon Pharmacy offers weight-loss drugs for $50 a month through Medicare bridge program

• The U.S. government's Medicare bridge program, launched last month, allows eligible beneficiaries to obtain drugs including Novo Nordisk's Wegovy in injection or pill form, as well as Eli Lilly's four-dose Zepbound KwikPen injection and the Foundayo pill, through the end of 2027. The program does not cover single-dose Zepbound vials or pens.
• Amazon Pharmacy said it would initiate the enrollment process on a customer's behalf once the patient adds insurance and Medicare details to their account and a clinician submits an electronic prescription.
• Many of the claims submitted have already resulted in completed orders, it said.
• Amazon Pharmacy launched electronic kiosks in its One Medical primary care locations last year to improve access and cut shipping costs.
• One Medical, a national primary care provider Amazon acquired in 2023, allows patients to access primary and urgent care for an annual subscription fee of $199.
• Same-day delivery is available in more than 3,100 U.S. cities and towns and is expected to expand to nearly 4,500 locations by the end of 2026, Amazon said.

Aug. 6 (Reuters) - Amazon's Amazon Pharmacy unit said on Thursday it would offer weight-loss drugs to eligible Medicare beneficiaries for $50 a month through a new federal program created to expand access to the highly sought-after treatments.